46. Malignant rheumatoid arthritis
4,183 clinical trials,   2,538 drugs   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01925157
(ClinicalTrials.gov)
August 201315/8/2013A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)A Single-Dose, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3090106 in Healthy Subjects and Subjects With Rheumatoid ArthritisRheumatoid ArthritisBiological: LY3090106 - SQ;Biological: LY3090106 - IV;Biological: Placebo - SQEli Lilly and CompanyNULLCompleted18 Years80 YearsBoth43Phase 1Bulgaria;Moldova, Republic of;Poland;Romania;Hungary;United States